GlassScriptPhysician profile
Charles J Dicorte
NPI 1043271612
$12,505.33
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,148 · 2020: $521 · 2021: $9,522 · 2022: $828 · 2023: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $317.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,902.08 | 2021 | |
| Abiomed | $1,052.28 | 2019-2023 | Impella |
| Medtronic Vascular, INC. | $653.35 | 2019-2020 | |
| Edwards Lifesciences Corporation | $498.46 | 2020-2022 | |
| Medtronic, INC. | $336.05 | 2021-2022 | |
| Atricure, INC. | $263.03 | 2022-2023 | |
| Bard Access Systems, INC. | $162.90 | 2019 | |
| Ethicon INC. | $133.16 | 2021 | |
| Davol INC. | $129.37 | 2022 | |
| Covidien LP | $111.51 | 2019 | |
| Becton, Dickinson and Company | $57.69 | 2019 | |
| Ethicon US, LLC | $23.66 | 2020 | |
| Boston Scientific Corporation | $13.53 | 2023 | Watchman Flx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Dicorte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.